MENU
+Compare
NVO
Stock ticker: NYSE
AS OF
Sep 3, 04:59 PM (EDT)
Price
$56.77
Change
+$0.38 (+0.67%)
Capitalization
254.04B

NVO Novo-Nordisk A/S Forecast, Technical & Fundamental Analysis

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more

NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NVO with price predictions
Sep 02, 2025

NVO's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for NVO turned positive on August 14, 2025. Looking at past instances where NVO's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NVO's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 13, 2025. You may want to consider a long position or call options on NVO as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVO advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 72 cases where NVO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NVO broke above its upper Bollinger Band on August 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.515) is normal, around the industry mean (9.469). P/E Ratio (14.430) is within average values for comparable stocks, (23.843). Projected Growth (PEG Ratio) (1.529) is also within normal values, averaging (1.759). Dividend Yield (0.031) settles around the average of (0.027) among similar stocks. P/S Ratio (5.141) is also within normal values, averaging (3.421).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVO is expected to report earnings to rise 2.78% to 95 cents per share on November 05

Novo-Nordisk A/S NVO Stock Earnings Reports
Q3'25
Est.
$0.95
Q2'25
Est.
$0.93
Q1'25
Beat
by $5.64
Q4'24
Beat
by $5.46
Q3'24
Beat
by $5.24
The last earnings report on August 06 showed earnings per share of 92 cents, missing the estimate of 93 cents. With 4.02M shares outstanding, the current market capitalization sits at 254.04B.
A.I.Advisor
published Dividends

NVO paid dividends on August 26, 2025

Novo-Nordisk A/S NVO Stock Dividends
А dividend of $0.58 per share was paid with a record date of August 26, 2025, and an ex-dividend date of August 18, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
LAZIO.X0.9185090.031935
+3.60%
S.S. Lazio Fan Token cryptocurrency
IAS8.96-0.03
-0.33%
Integral Ad Science Holding Corp
ZWS45.12-0.24
-0.53%
Zurn Elkay Water Solutions Corp
TURN4.92-0.06
-1.30%
180 Degree Capital Corp
OPRX17.16-0.91
-5.04%
OptimizeRx Corp

NVO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been loosely correlated with ADAP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NVO jumps, then ADAP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-0.14%
ADAP - NVO
38%
Loosely correlated
-1.87%
GMAB - NVO
35%
Loosely correlated
+4.10%
TECH - NVO
35%
Loosely correlated
-2.21%
BCAB - NVO
35%
Loosely correlated
-1.67%
MRK - NVO
34%
Loosely correlated
+1.62%
More

Groups containing NVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
-0.14%
Pharmaceuticals: Major
industry (61 stocks)
40%
Loosely correlated
+0.03%